Researchers have injected human stem cells into primate embryos and were able to grow chimeric embryos for a significant period of time -- up to 20 days. The research, despite its ethical concerns, has the potential to provide new insights into developmental biology and evolution. It also has implications for developing new models of human biology and disease.
From:
Cell Press
April 15, 2021 -- Investigators in China
and the United States have injected human stem cells into primate embryos and
were able to grow chimeric embryos for a significant period of time -- up to 20
days. The research, despite its ethical concerns, has the potential to provide
new insights into developmental biology and evolution. It also has implications
for developing new models of human biology and disease. The work appears April
15 in the journal Cell.
"As we are unable to conduct
certain types of experiments in humans, it is essential that we have better
models to more accurately study and understand human biology and disease,"
says senior author Juan Carlos Izpisua Belmonte, a professor in the Gene
Expression Laboratory at the Salk Institute for Biological Sciences. "An
important goal of experimental biology is the development of model systems that
allow for the study of human diseases under in vivo conditions."
Interspecies chimeras in mammals have
been made since the 1970s, when they were generated in rodents and used to
study early developmental processes. The advance that made the current study
possible came last year when this study's collaborating team -- led by Weizhi
Ji of Kunming University of Science and Technology in Yunnan, China --
generated technology that allowed monkey embryos to stay alive and grow outside
the body for an extended period of time.
In the current study, six days after the
monkey embryos had been created, each one was injected with 25 human cells. The
cells were from an induced pluripotent cell line known as extended pluripotent
stem cells, which have the potential to contribute to both embryonic and
extra-embryonic tissues. After one day, human cells were detected in 132
embryos. After 10 days, 103 of the chimeric embryos were still developing.
Survival soon began declining, and by day 19, only three chimeras were still
alive. Importantly, though, the percentage of human cells in the embryos
remained high throughout the time they continued to grow.
"Historically, the generation of
human-animal chimeras has suffered from low efficiency and integration of human
cells into the host species," Izpisua Belmonte says. "Generation of a
chimera between human and non-human primate, a species more closely related to
humans along the evolutionary timeline than all previously used species, will
allow us to gain better insight into whether there are evolutionarily imposed
barriers to chimera generation and if there are any means by which we can
overcome them."
The investigators performed
transcriptome analysis on both the human and monkey cells from the embryos.
"From these analyses, several communication pathways that were either
novel or strengthened in the chimeric cells were identified," Izpisua
Belmonte explains. "Understanding which pathways are involved in chimeric
cell communication will allow us to possibly enhance this communication and
increase the efficiency of chimerism in a host species that's more evolutionarily
distant to humans."
An important next step for this research
is to evaluate in more detail all the molecular pathways that are involved in
this interspecies communication, with the immediate goal of finding which
pathways are vital to the developmental process. Longer term, the researchers
hope to use the chimeras not only to study early human development and to model
disease, but to develop new approaches for drug screening, as well as
potentially generating transplantable cells, tissues, or organs.
An accompanying Preview in Cell outlines
potential ethical considerations surrounding the generation of human/non-human
primate chimeras. Izpisua Belmonte also notes that "it is our
responsibility as scientists to conduct our research thoughtfully, following
all the ethical, legal, and social guidelines in place." He adds that
before beginning this work, "ethical consultations and reviews were
performed both at the institutional level and via outreach to non-affiliated
bioethicists. This thorough and detailed process helped guide our
experiments."
No comments:
Post a Comment